Browse By Person: Russell, Pamela
 | Up a level |
Group by: Item Type | Date
Number of items: 58.
2005
Aghmesheh, Morteza, Edwards, Lyndal, Clarke, Christine, Byth, Karen, Katzenellenbogen, Benita, Russell, Pamela, et al. (2005) Expression of steroid hormone receptors in BRCA1-associated ovarian carcinomas. Gynecologic Oncology, 97(1), pp. 16-25.
2 
2
2 2Yang, Jia-Lin, Qu, Xian-Jun, Russell, Pamela, & Goldstein, David (2005) Interferon-alpha promotes the anti-proliferative effect of Erlotinib (OSI-774) on human colon cancer cell lines. Cancer Letters, 225(1), pp. 61-74.
5 5
5 5Yang, Jia-Lin, Qu, Xian-Jun, Russell, Pamela, & Goldstein, David (2005) Interferon-alpha promotes the anti-proliferative effect of gefitinib (ZD 1839) on human colon cancer cell lines. Oncology: international journal of cancer research and treatment, 69(3), pp. 224-238.
10 9
10 9Cozzi, Paul, Wang, Jian, Delprado, Warick, Perkins, Alan, Allen, Barry, Russell, Pamela, et al. (2005) MUC1, MUC2, MUC4, MUC5AC and MUC6 expression in the progression of prostate cancer. Clinical and Experimental Metastasis, 22(7), pp. 565-573.
49 41
49 41Bauskin, Asne, Brown, David, Junankar, Simon, Rasiah, Krishan, Eggleton, Sarah, Hunter, Mark, et al. (2005) The propeptide mediates formation of stromal stores of PROMIC-1: Role in determining prostate cancer outcome. Cancer Research, 65(6), pp. 2330-2336.
48 45
48 452006
Khatri, Aparajita, Zhang, Bing, Doherty, Eboney, Chapman, Jane, Ow, Kim, Pwint, Hnin, et al. (2006) Combination of cytosine deaminase with uracil phosphoribosyl transferase leads to local and distant bystander effects against RM1 prostate cancer in mice. Journal of Gene Medicine, 8(9), pp. 1086-1096.
23 24
23 24Wang, Jian, Abbas Rizvi, Syed, Madigan, Michele, Cozzi, Paul, Power, Carl, Qu, Chang, et al. (2006) Control of prostate cancer spheroid growth using 213Bi-labeled multiple targeted alpha radioimmunoconjugates. The Prostate, 66(16), pp. 1753-1767.
13 8
13 8Cozzi, Paul, Wang, Jian, Delprado, Warick, Madigan, Michele, Fairy, Stephen, Russell, Pamela, et al. (2006) Evaluation of urokinase plasminogen activator and its receptor in different grades of human prostate cancer. Human Pathology, 37(11), pp. 1442-1451.
44 39
44 39Yang, Jia-Lin, Hannan, M., Russell, Pamela, & Crowe, Philip (2006) Expression of HER1/EGFR protein in human soft tissue sarcomas. European Journal of Surgical Oncology, 32(4), pp. 466-468.
8 10
8 10Brown, David, Stephan, Carsten, Ward, Robyn, Law, Mathew, Hunter, Mark, Bauskin, Asne, et al. (2006) Measurement of serum levels of macrophage inhibitory cytokine 1 combined with prostate-specific antigen improves prostate cancer diagnosis. Clinical Cancer Research, 12(1), pp. 89-96.
45 41
45 41Dong, Qihan, Patel, Manish, Scott, Kieran, Graham, Garry, Russell, Pamela, & Sved, Paul (2006) Oncogenic action of phospholipase A2 in prostate cancer. Cancer Letters, 240(1), pp. 9-16.
35 35
35 35Perryman, Lara, Blair, Julie, Kingsley, Elizabeth, Szymanska, Barbara, Ow, Kim, Wen, Victoria, et al. (2006) Over-expression of p53 mutants in LNCaP cells alters tumor growth and angiogenesis in vivo. Biochemical and Biophysical Research Communications, 345(3), pp. 1207-1214.
8 7
8 7Zhang, An Ling & Russell, Pamela (2006) Paclitaxel suppresses the growth of primary prostate tumours (RM-1) and metastases in the lung in C57BL/6 mice. Cancer Letters, 233(1), pp. 185-191.
7 5
7 52007
Vandyke, Kate, Jackson, Paul, Rowe, Alexandra, Russell, Pamela, & Blair, Julie (2007) Androgen decreases osteoprotegerin expression in prostate cancer cells. Prostate Cancer and Prostatic Diseases, 10(2), pp. 160-166.
Yang, Jia-Lin, Qu, Xian-Jun, Hayes, Vanessa, Brenner, Phillip, Russell, Pamela, & Goldstein, David (2007) Erlotinib (OSI-774)-induced inhibition of transitional cell carcinoma of bladder cell line growth is enhanced by interferon-alpha. BJU International, 99(6), pp. 1539-1545.
12 7
12 7Khatri, Aparajita, Husaini, Yasmin, & Russell, Pamela (2007) Murine CTLL-2 cells respond to mIL12: Prospects for developing an alternative bioassay for measurement of murine cytokines IL12 and IL18. Journal of Immunological Methods, 326(1-2), pp. 41-53.
3 3
3 3Zhang, An Ling, Russell, Pamela, Knittel, Tony, & Milross, Chris (2007) Paclitaxel enhanced radiation sensitization for the suppression of human prostate cancer tumor growth via a p53 independent pathway. The Prostate, 67(15), pp. 1630-1640.
6 4
6 4Vandyke, Kate, White, Melanie, Nguyen-Khuong, Terry, Ow, Kim, Luk, Sharon, Kingsley, Elizabeth, et al. (2007) Plant derived MINA-05 inhibits human prostate cancer proliferation in vitro and lymph node spread in vivo. NeoPlasia: an international journal of oncology research, 9(4), pp. 322-331.
7 7
7 7Skalicky, Simon, Ow, Kim, Hannan, M., Russell, Pamela, & Yang, Jia-Lin (2007) p53 expression is associated with malignant potential in xenograft tissues of a fibrosarcoma mouse model. Anticancer Research: international journal of cancer research and treatment, 27(2), pp. 973-978.
3 2
3 22008
Jeet, Varinder, Ow, Kim, Doherty, Eboney, Curley, Ben, Russell, Pamela, & Khatri, Aparajita (2008) Broadening of transgenic adenocarcinoma of the mouse prostate (TRAMP) model to represent late stage androgen depletion independent cancer. The Prostate, 68(5), pp. 548-562.
3 3
3 3Farhadieh, Ross, Smee, Robert, Salardini, Arash, Ow, Kim, Yang, Jia-Lin, & Russell, Pamela (2008) Correlation between p33ING1b cytoplasmic transfer and lymph node metastasis in oral squamous cell carcinoma. Iranian Journal of Medical Sciences, 33(1), pp. 27-32.
Patel, Manish, Singh, Jas, Niknami, Marzieh, Kurek, Caroline, Yao, Mu, Lu, Sasa, et al. (2008) Cytosolic phospholipase A2-a: A potential therapeutic target for prostate cancer. Clinical Cancer Research, 14(24), pp. 8070-8079.
21 19
21 19Hung, Tzong-Tyng, Wang, Hong, Kingsley, Elizabeth, Risbridger, Gail, & Russell, Pamela (2008) Molecular profiling of bladder cancer: Involvement of the TGF-ß pathway in bladder cancer progression. Cancer Letters, 265(1), pp. 27-38.
9 10
9 10Abbas Rizvi, Syed, Song, Emma Yan Jun, Raja, Chand, Beretov, Julia, Morgenstern, Alfred, Apostolidis, Christos, et al. (2008) Preparation and testing of bevacizumab radioimmunoconjugates with Bismuth-213 and Bismuth-205 / Bismuth-206. Cancer Biology and Therapy, 7(10), pp. 1548-1555.
8
8Barnetson, Anthony, Milross, Chris, & Russell, Pamela (2008) An investigation of fludarabine as a potential radiation sensitizer of human prostate cancer cells in vitro. Asia Pacific Journal of Clinical Oncology, 4(1), pp. 48-54.
Madigan, Michele, Kingsley, Elizabeth, Cozzi, Paul, Delprado, Warick, Russell, Pamela, & Li, Yong (2008) The role of extracellular matrix metalloproteinase inducer protein in prostate cancer progression. Cancer Immunology, Immunotherapy: other biological response modifications, 57(9), pp. 1367-1379.
24 20
24 202009
Nguyen-Khuong, Terry, White, Melanie, Hung, Tzong-Tyng, Seeto, Shona, Thomas, Melissa, Fitzgerald, Anna, et al. (2009) Alterations to the protein profile of bladder carcinoma cell lines induced by plant extract MINA-05 in vitro. Proteomics, 9(7), pp. 1883-1892.
2 2
2 2Khatri, Aparajita, Husaini, Yasmin, Ow, Kim, Chapman, Jane, & Russell, Pamela (2009) Cytosine deaminase-uracil phosphoribosyltransferase and interleukin (IL)-12 and IL-18: a multimodal anticancer interface marked by specific modulation in serum cytokines. Clinical Cancer Research, 15(7), pp. 2323-2334.
11 9
11 9Li, Yong, Song, Emma Yan Jun, Abbas Rizvi, Syed, Power, Carl, Beretov, Julia, Raja, Chand, et al. (2009) Inhibition of micrometastatic prostate cancer cell spread in animal models by 213Bilabeled multiple targeted alpha radioimmunoconjugates. Clinical Cancer Research, 15(3), pp. 865-875.
6 7
6 7Thierry, Benjamin, Al-Ejeh, Fares, Khatri, Aparajita, Yuan, Zhe, Russell, Pamela, Ping, Sue, et al. (2009) Multifunctional core - shell magnetic cisplatin nanocarriers. Chemical Communications, 2009(47), pp. 7348-7350.
10 6
10 6Farhadieh, Ross, Smee, Robert, Rees, Charles, Salardini, Arash, Eggleton, Sarah, Yang, Jia-Lin, et al. (2009) Mutant p53 and cyclin A1 protein expression in primary laryngeal squamous cell carcinomas do not correlate to second primary tumours of the head and neck. ANZ Journal of Surgery, 79(1-2), pp. 48-54.
3 3
3 3Farhadieh, Ross, Salardini, Arash, Rees, Charles, Russell, Pamela, Yang, Jia-Lin, & Smee, Robert (2009) Protein expression of epidermal growth factor receptor in laryngeal squamous cell carcinoma index tumors correlates with diagnosis of second primary tumors of the upper aerodigestive tract. Annals of Surgical Oncology, 16(10), pp. 2888-2894.
4 4
4 4Farhadieh, Ross, Rees, Charles, Yang, Jia-Lin, Salardini, Arash, Russell, Pamela, & Smee, Robert (2009) Radiotherapy in larynx squamous cell carcinoma is not associated with an increased diagnosis of second primary tumours. Clinical Oncology, 21(4), pp. 315-319.
5 3
5 3Farhadieh, Ross, Otahal, Petr, Rees, Charles, Salardini, Arash, Russell, Pamela, & Smee, Robert (2009) Radiotherapy is not associated with an increased rate of Second Primary Tumours in Oral Squamous Carcinoma: A study of 370 patients. Oral Oncology, 45(11), pp. 941-945.
3 3
3 3de Souza, Paul, Russell, Pamela, & Kearsley, John (2009) Role of the Akt pathway in prostate cancer. Current Cancer Drug Targets, 9(2), pp. 163-175.
13 13
13 13Power, Carl, Pwint, Hnin, Chan, Jeffrey, Cho, Jae, Yu, Yan, Walsh, William, et al. (2009) A novel model of bone-metastatic prostate cancer in immunocompetent mice. The Prostate, 69(15), pp. 1613-1623.
10 9
10 92010
de Souza, Paul, Russell, Pamela, Kearsley, John, & Howes, Laurence (2010) Clinical pharmacology of isoflavones and its relevance for potential prevention of prostate cancer. Nutrition Reviews, 68(9), pp. 542-555.
14 11
14 11Hao, J., Chen, H., Madigan, Michele, Cozzi, Paul, Beretov, Julia, Xiao, W., et al. (2010) Co-expression of CD147 (EMMPRIN), CD44v3-10, MDR1 and monocarboxylate transporters is associated with prostate cancer drug resistance and progression. British Journal of Cancer, 103(7), pp. 1008-1018.
18 14
18 14Tang, Catherine, Russell, Pamela, Martiniello-Wilks, Rosetta, Rasko, John, & Khatri, Aparajita (2010) Concise Review: Nanoparticles and cellular carriers - allies in cancer imaging and cellular gene therapy? Stem Cells, 28(9), pp. 1686-1702.
20 16
20 16Farhadieh, Ross, Salardini, Arash, Yang, Jia-Lin, Russell, Pamela, & Smee, Robert (2010) Diagnosis of second head and neck tumors in primary laryngeal SCC is an indicator of overall survival and not associated with poorer overall survival: A single centre study in 987 patients. Journal of Surgical Oncology, 101(1), pp. 72-77.
5
5Scott, Kieran, Sajinovic, Mila, Hein, Juliane, Nixdorf, Sheri, Galettis, Peter, Liauw, Winston, et al. (2010) Emerging roles for phospholipase A2 enzymes in cancer. Biochimie, 92(6), pp. 601-610.
21 18
21 18You, Jingjing, Cozzi, Paul, Walsh, Bradley, Willcox, Mark, Kearsley, John, Russell, Pamela, et al. (2010) Innovative biomarkers for prostate cancer early diagnosis and progression. Critical Reviews in Oncology / Hematology, 73(1), pp. 10-22.
16 10
16 10Jeet, Varinder, Russell, Pamela, & Khatri, Aparajita (2010) Modeling prostate cancer: a perspective on transgenic mouse models. Cancer and Metastasis Reviews, 29(1), pp. 123-142.
15 11
15 11Singh, P, Yam, M, Russell, Pamela, & Khatri, Aparajita (2010) Molecular and traditional chemotherapy: A united front against prostate cancer. Cancer Letters, 293(1), pp. 1-14.
6 4
6 4You, Jingjing, Fitzgerald, Anna, Cozzi, Paul, Zhao, Zhenjun, Graham, Peter, Russell, Pamela, et al. (2010) Post-translation modification of proteins in tears. Electrophoresis, 31(11), pp. 1853-1861.
11 10
11 10Li, Yong, Cozzi, Paul, & Russell, Pamela (2010) Promising tumor-associated antigens for future prostate cancer therapy. Medicinal Research Reviews, 30(1), pp. 67-101.
6 4
6 4You, Jingjing, Madigan, Michele, Rowe, Alexandra, Sajinovic, Mila, Russell, Pamela, & Jackson, Paul (2010) An inverse relationship between KAI1 expression, invasive ability, and MMP-2 expression and activity in bladder cancer cell lines. Urologic Oncology: Seminars and Original Investigations, Online(Online), pp. 1-7.
2011
Talukdar, Sarmistha, Mandal, Mahitosh, Hutmacher, Dietmar W., Russell, Pamela J., Soekmadji, Carolina, & Kundu, Subhas C. (2011) Engineered silk fibroin protein 3D matrices for in vitro tumor model. Biomaterials, 32, pp. 2149-2159.
12 11
12 11Tse, Brian Wan-Chi, Russell, Pamela, Lochner, Matthias, Forster, Irmgard, & Power, Carl (2011) IL-18 inhibits growth of murine orthotopic prostate carcinomas via both adaptive and innate immune mechanisms. PLoS ONE, 6(9), pp. 1-12.
7 4
7 4Singh, Preetinder Pal, Joshi, Swapna, Russell, Pamela, Verma, Nirupama, Wang, Xiaochun, & Khatri, Aparajita (2011) Molecular chemotherapy and chemotherapy: A new front against late-stage hormone-refractory prostate cancer. Clinical Cancer Research, 17(12), pp. 4006-4018.
3 2
3 2Singh, Preetinder, Joshi, Swapna, Russell, Pamela, Nair, Sham, & Khatri, Aparajita (2011) Purine Nucleoside Phosphorylase mediated molecular chemotherapy and conventional chemotherapy: A tangible union against chemoresistant cancer. BMC Cancer, pp. 1-15.
2 2
2 2Hung, Tzong-Tyng, Chan, Jeffrey, Russell, Pamela, & Power, Carl (2011) Zoledronic acid preserves bone structure and increases survival but does not limit tumour incidence in a prostate cancer bone metastasis model. PLoS ONE, 6(5), pp. 1-8.
5 4
5 42012
Husaini, Yasmin, Qiu, Min Ru, Lockwood, Glen P., Luo, Xu Wei, Shang, Ping, Kuffner, Tamara, et al. (2012) Macrophage inhibitory cytokine-1 (MIC-1/GDF15) slows cancer development but increases metastases in TRAMP prostate cancer prone mice. PLoS ONE, 7(8), e43833.
9 1 1
9 1 1Jingjing, You, Cozzi, Paul, Fitzgerald , Anna, Walsh, Bradley, Russell, Pamela J., Willcox, Mark, et al. (2012) Prostate cancer biomarkers and the emerging proteomic techniques used in biomarker research. In Watanabe, Hiroto S. (Ed.) Horizons in Cancer Research : Volume 47. Nova Science Publishers Inc, New York, pp. 1-36.
Jeet, Varinder, Russell, Pamela J., Verma, Nirupama D., & Khatri, Aparajita (2012) Targeting aurora kinases : a novel approach to curb the growth and chemoresistance of androgen refractory prostate cancer. Current Cancer Drug Targets, 12(2), pp. 144-163.
Soekmadji, Carolina, Russell, Pamela, & Nelson, Colleen C. (2012) Exosomes as biomarkers for prostate cancer progression and drug resistance. In International Society for Extracellular Vesicles, 18-21 April 2012, Sweden.
Tse, Brian Wan-Chi, Scott, Kieran F, & Russell, Pamela J. (2012) Paradoxical roles of tumour necrosis factor-alpha in prostate cancer biology. Prostate Cancer, 2012, pp. 1-8.
15
15Russell, Pamela (2012) Use of targeted magnetic nanoparticles for Magnetic Resonance Imaging of prostate cancer. In The 19th Annual Prostate Cancer Foundation Scientific Retreat, 25 - 27 October 2012, San Diego, CA.